Since cancer patient’s immune system is intact, and ZD55-IL-24 can infect, directly lyse and express exogenous IL-24 in human cancer cells within patient’s tumors, we thus speculate that all the antitumor pathways are probably able to act synergistically in patients. The gene discussed is IL24; the disease is cancer.